title: VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo.
abstract: A novel member of the tumor necrosis factor (TNF) family has been identified from the human umbilical vein endothelial cell cDNA library, named vascular endothelial growth inhibitor (VEGI). The VEGI gene was mapped to human chromosome 9q32. The cDNA for VEGI encodes a protein of 174 amino acid residues with the characteristics of a type II transmembrane protein. Its amino acid sequence is 20-30% identical to other members of the TNF family. Unlike other members of the TNF family, VEGI is expressed predominantly in endothelial cells. Local production of a secreted form of VEGI via gene transfer caused complete suppression of the growth of MC-38 murine colon cancers in syngeneic C57BL/6 mice. Histological examination showed marked reduction of vascularization in MC-38 tumors that expressed soluble but not membrane-bound VEGI or were transfected with control vector. The conditioned media from soluble VEGI-expressing cells showed marked inhibitory effect on in vitro proliferation of adult bovine aortic endothelial cells. Our data suggest that VEGI is a novel angiogenesis inhibitor of the TNF family and functions in part by directly inhibiting endothelial cell proliferation. The results further suggest that VEGI maybe highly valuable toward angiogenesis-based cancer therapy.
authors.affiliation: Human Genome Sciences, Inc., Rockville, Maryland 20850, USA. Yifan_Zhai@hgsi.com
authors.forename: Y
authors.initials: Y
authors.lastname: Zhai
authors.forename: J
authors.initials: J
authors.lastname: Ni
authors.forename: G W
authors.initials: GW
authors.lastname: Jiang
authors.forename: J
authors.initials: J
authors.lastname: Lu
authors.forename: L
authors.initials: L
authors.lastname: Xing
authors.forename: C
authors.initials: C
authors.lastname: Lincoln
authors.forename: K C
authors.initials: KC
authors.lastname: Carter
authors.forename: F
authors.initials: F
authors.lastname: Janat
authors.forename: D
authors.initials: D
authors.lastname: Kozak
authors.forename: S
authors.initials: S
authors.lastname: Xu
authors.forename: L
authors.initials: L
authors.lastname: Rojas
authors.forename: B B
authors.initials: BB
authors.lastname: Aggarwal
authors.forename: S
authors.initials: S
authors.lastname: Ruben
authors.forename: L Y
authors.initials: LY
authors.lastname: Li
authors.forename: R
authors.initials: R
authors.lastname: Gentz
authors.forename: G L
authors.initials: GL
authors.lastname: Yu
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism*; D001483:Base Sequence; D002455:Cell Division; D002460:Cell Line; D003110:Colonic Neoplasms / Q000503:physiopathology*; D018076:DNA, Complementary; D004730:Endothelium, Vascular / Q000166:cytology; D015870:Gene Expression; D006801:Humans; D051379:Mice; D008810:Mice, Inbred C57BL; D008969:Molecular Sequence Data; D009389:Neovascularization, Pathologic; D012995:Solubility; D014407:Tumor Cells, Cultured; D053380:Tumor Necrosis Factor Ligand Superfamily Member 15; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D018076:DNA, Complementary; C117026:TNFSF15 protein, human; D053380:Tumor Necrosis Factor Ligand Superfamily Member 15; D014409:Tumor Necrosis Factor-alpha